Cargando…
An Update on the Prognostic and Predictive Serum Biomarkers in Metastatic Prostate Cancer
Serum biomarkers are molecules produced by normal and abnormal cells. Prostate specific antigen (PSA) is an example of a serum biomarker used widely in the diagnosis and prognostication of prostate cancer. PSA has its limitations as it is organ- but not cancer-specific. The aim of this review is to...
Autores principales: | Saxby, Helen, Mikropoulos, Christos, Boussios, Stergios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7459446/ https://www.ncbi.nlm.nih.gov/pubmed/32752137 http://dx.doi.org/10.3390/diagnostics10080549 |
Ejemplares similares
-
Androgen Receptor Gene Pathway Upregulation and Radiation Resistance in Oligometastatic Prostate Cancer
por: Saxby, Helen, et al.
Publicado: (2022) -
State-of-the-Art Molecular Oncology in UK
por: Sandoughdaran, Saleh, et al.
Publicado: (2023) -
Recent Insights into PARP and Immuno-Checkpoint Inhibitors in Epithelial Ovarian Cancer
por: Revythis, Antonios, et al.
Publicado: (2022) -
Prognostic Factors in Patients with Metastatic Spinal Cord Compression Secondary to Lung Cancer—A Retrospective UK Single-Centre Study
por: Vassiliou, Anna, et al.
Publicado: (2023) -
Wise Management of Ovarian Cancer: On the Cutting Edge
por: Boussios, Stergios, et al.
Publicado: (2020)